Gary Ablett Jr. Gets His Gameday On
Published 08-DEC-2016 15:25 P.M.
|
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Brownlow medallist and dual AFL premiership player Gary Ablett Jr. has joined Gameday International, a wholly owned subsidiary of Impression Healthcare (ASX:IHL) as its latest ambassador.
The AFL legend who has captained the Gold Coast Suns since his departure from Geelong Football Club in 2010, will promote Gameday via advertising and other marketing activities to build brand awareness around Gameday Mouthguards and future products.
Gameday manufactures custom mouthguards at an affordable price making them accessible to all Australian sports participants.
However it is still an early stage company and investors considering this stock for their portfolio, should seek professional financial advice.
It expected Ablett’s involvement will bring awareness through the entire AFL community, from grassroots level to more senior leagues.
The eight-time All-Australian will be looked upon to promote a message of safe play through grass roots media related activity, as well as the benefits of wearing a custom-made mouthguard.
Ablett will attend school clinics and use social media to work with Gameday to produce and promote a limited edition mouthguard to be named after the champion: Gary Ablett Jnr. Limited Edition Mouthguards.
“I’m incredibly excited to be involved with Gameday. Gameday’s custom-fit mouthguards are an incredible product, providing an affordable high quality option for all the players out there who should be wearing protective mouthguards when playing sports. As someone how is passionate about encouraging children to play Australian Rules Football, it’s really important to promote the message of safe play and mouthguard use at the same time.”
Ablett’s signing comes just weeks after two prominent players from the AFLW signed on as Gameday ambassadors.
Ablett will join high profile professional women’s AFL players, Moana Hope and Kaitlyn Ashmore, as Gameday’s AFL representatives.
The AFLW players joined Gameday just as IHL debuted on the ASX in November.
As part of his consideration, Ablett will be issued with 625,000 shares in Impression Healthcare, further aligning his interests with the company.
General Information Only
This material has been prepared by Jason Price. Jason Price is an authorised representative (AR 000296877) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573) (62C), and a Director of S3 Consortium Pty Ltd (trading as StocksDigital).
This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Jason Price, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, Jason Price, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
